Erika Johnsson

Ms Johnsson is currently Chief Financial Officer of the Novo Nordisk Foundation, which she joined in November 2023. She is also currently a member of the board of directors of Saab AB and Camurus AB. Previously, she held various CFO roles at organizations including Kinnevik AB (2020 to 2022), where she also served as a Senior Adviser from 2022 2023, Biotage AB (2012 to 2020), Karo Bio AB (2007 to 2011), Affibody AB (2005 to 2007) and Global Genomics AB (2002 to 2005). Prior board positions include Sectra AB (2007 to 2017), MedCap AB (2014 to 2017), Qliro Group AB (2017 to 2020), Lunar Group A/S (2020 to 2023) and Mabtech Holding AB (2023 to 2024).